De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on generics.

Author: BonanBrigitte, Chan Hew WaiAurelie, DoisneMelanie, FournErwan, GiraudJean-Stephane, MajerholcCatherine, SejeanKarine, TrichereauJulie, ZucmanDavid

Paper Details 
Original Abstract of the Article :
In developed countries, most people living with HIV/AIDS are treated with costly brand single-tablet regimens. Given the economic impact, French guidelines recommend using generic antiretroviral therapy when possible to decrease antiretroviral therapy costs. We aimed to study HIV-infected patients' ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518587/

データ提供:米国国立医学図書館(NLM)

Navigating the Cost-Saving Landscape of Antiretroviral Therapy: A Patient-Centered Approach

In the ongoing fight against [HIV/AIDS], access to effective and affordable treatment remains a paramount concern. This research explores the feasibility and acceptability of simplifying single-tablet antiretroviral regimens in France, a strategy aimed at reducing treatment costs. The study takes a patient-centered approach, focusing on the perspectives of individuals living with HIV/AIDS. The research examines the factors influencing patients' willingness to switch from expensive brand-name single-tablet regimens to a more cost-effective regimen involving two generic pills. This study sheds light on the complexities of balancing cost-effectiveness with patient preferences and highlights the importance of patient-centered decision-making in healthcare.

De-simplifying Regimens: A Cost-Effective Approach

The research demonstrates that a significant portion of patients living with HIV/AIDS in France are willing to embrace a de-simplified antiretroviral regimen, even if it means taking two pills instead of one. The study revealed that 51 out of 98 patients in the cohort were willing to switch to the de-simplified regimen, indicating a positive receptiveness towards cost-saving measures. This finding highlights the potential of simplifying antiretroviral regimens as a viable strategy for reducing treatment costs while maintaining patient satisfaction.

Cost-Effectiveness and Patient Satisfaction: Finding the Right Balance

This research underscores the importance of finding the right balance between cost-effectiveness and patient satisfaction when it comes to antiretroviral therapy. The study reveals that while cost-savings are a significant motivator for patients, the number of pills required remains a key concern. This finding emphasizes the need for a patient-centered approach to decision-making, ensuring that treatment options are tailored to individual needs and preferences. This research encourages further exploration of innovative approaches that can effectively address the challenges of cost, patient satisfaction, and treatment adherence in the management of HIV/AIDS.

Dr.Camel's Conclusion

This research, like the vast desert landscape, reveals the complexities and challenges of navigating healthcare systems. The study highlights the importance of patient-centered care, particularly when considering cost-saving measures for antiretroviral therapy. By taking into account patient perspectives, we can develop more effective and sustainable approaches to managing HIV/AIDS, ensuring that treatment remains accessible and affordable.

Date :
  1. Date Completed 2020-11-13
  2. Date Revised 2020-11-13
Further Info :

Pubmed ID

32976493

DOI: Digital Object Identifier

PMC7518587

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.